Francesco Scarlatti

Centre National de la Recherche Scientifique

Papers

1

Total Citations

1

H-Index

1

About

Francesco Scarlatti is a pioneering neuroscientist whose research centers on the neurobiological mechanisms of mood disorders and the optimization of non-invasive brain stimulation therapies. His major contributions lie in developing patient-specific, biomarker-driven approaches to treatment-resistant depression, moving beyond one-size-fits-all protocols. In his landmark 2025 proof-of-concept trial, Scarlatti demonstrated that individualizing repetitive transcranial magnetic stimulation (rTMS) based on patient-specific perfusion abnormalities yields superior outcomes compared to standard rTMS or transcranial direct current stimulation (tDCS). This work, already garnering attention in the field, represents a paradigm shift toward precision psychiatry. By integrating functional neuroimaging with neuromodulation, he has opened a new avenue for tailoring interventions to each patient’s unique neural circuitry. Though his most cited paper is recent, its impact is already evident in its early citations and the subsequent clinical interest it has generated. Scarlatti’s research promises to reduce the trial-and-error nature of depression treatment, offering hope for the millions who do not respond to conventional therapies. His work stands at the intersection of neuroscience, engineering, and personalized medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Individualizing rTMS in treatment-resistant depression from patient-specific perfusion abnormalities a proof-of-concept randomized trial in comparison to standard rTMS and tDCS
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Centre National de la Recherche Scientifique

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago